Back to GetFilings.com



Click here to Index

 
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C.
20549
 
FORM 10-Q
 
For the Quarter Ended
December 31, 2004
 
Commission file number 1-2661
 
CSS INDUSTRIES, INC.

(Exact name of registrant as specified in its Charter)
 
Delaware
 
13-1920657

 

(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification number)
 
 
 
1845 Walnut Street, Philadelphia, PA
 
19103

 

(Address of principal executive offices)
 
(Zip Code)
 
(215) 569-9900

(Registrant’s telephone number, including area code)
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
 
Yes                                No  
 
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act).
 
Yes                                No  
 
As of January 25, 2005, there were 11,977,799 shares of common stock outstanding which excludes shares which may still be issued upon exercise of stock options.
 

CSS INDUSTRIES, INC. AND SUBSIDIARIES
 
INDEX
 
 
PAGE NO.
 

PART I - FINANCIAL INFORMATION
 
 
 
Item 1. Financial Statements
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 2 of 24

Back to Index
 
CSS INDUSTRIES, INC. AND SUBSIDIARIES
 
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
(Unaudited)
 
 
 
Three Months Ended
December 31,
 
Nine Months Ended
December 31,
 
 
 

 

 
(In thousands, except
per share data)
 
2004
 
2003
 
2004
 
2003
 

 

 

 

 

 
SALES
 
$
247,169
 
$
247,394
 
$
478,435
 
$
484,846
 
 
 


 


 


 


 
COSTS AND EXPENSES
 
 
 
 
 
 
 
 
 
 
 
 
 
Cost of sales
 
 
184,656
 
 
176,443
 
 
353,270
 
 
350,718
 
Selling, general and administrative expenses
 
 
24,221
 
 
27,048
 
 
68,984
 
 
73,036
 
Interest expense, net
 
 
906
 
 
1,185
 
 
2,032
 
 
2,874
 
Other expense (income), net
 
 
49
 
 
192
 
 
(643
)
 
(310
)
 
 


 


 


 


 
 
 
 
209,832
 
 
204,868
 
 
423,643
 
 
426,318
 
 
 


 


 


 


 
INCOME BEFORE INCOME TAXES
 
 
37,337
 
 
42,526
 
 
54,792
 
 
58,528
 
INCOME TAX EXPENSE
 
 
13,366
 
 
15,129
 
 
19,615
 
 
20,954
 
 
 


 


 


 


 
NET INCOME
 
$
23,971
 
$
27,397
 
$
35,177
 
$
37,574
 
 
 


 


 


 


 
NET INCOME PER COMMON SHARE
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic
 
$
2.01
 
$
2.31
 
$
2.95
 
$
3.20
 
 
 


 


 


 


 
Diluted
 
$
1.91
 
$
2.18
 
$
2.79
 
$
3.05
 
 
 


 


 


 


 
WEIGHTED AVERAGE SHARES OUTSTANDING
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic
 
 
11,952
 
 
11,841
 
 
11,929
 
 
11,730
 
 
 


 


 


 


 
Diluted
 
 
12,523
 
 
12,592
 
 
12,607
 
 
12,335
 
 
 


 


 


 


 
CASH DIVIDENDS PER SHARE OF COMMON STOCK
 
$
.10
 
$
.08
 
$
.30
 
$
.227
 
 
 


 


 


 


 
COMPREHENSIVE INCOME
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income
 
$
23,971
 
$
27,397
 
$
35,177
 
$
37,574
 
Change in fair value of interest rate swap agreements, net
 
 
—  
 
 
149
 
 
—  
 
 
269
 
Foreign currency translation adjustment
 
 
(8
)
 
—  
 
 
(3
)
 
17
 
 
 


 


 


 


 
Comprehensive income
 
$
23,963
 
$
27,546
 
$
35,174
 
$
37,860
 
 
 


 


 


 


 
 
See notes to consolidated financial statements.
 
Page 3 of 24

Back to Index
 
CSS INDUSTRIES, INC. AND SUBSIDIARIES
 
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
 
(In thousands)
 
December 31,
2004
 
March 31,
2004
 

 

 

 
ASSETS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CURRENT ASSETS
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
18,845
 
$
93,191
 
Accounts receivable, net
 
 
214,715
 
 
40,460
 
Inventories
 
 
81,652
 
 
94,459
 
Deferred income taxes
 
 
7,491
 
 
7,937
 
Other current assets
 
 
13,719
 
 
12,987
 
 
 


 


 
Total current assets
 
 
336,422
 
 
249,034
 
 
 


 


 
PROPERTY, PLANT AND EQUIPMENT, NET
 
 
77,681
 
 
81,193
 
 
 


 


 
OTHER ASSETS
 
 
 
 
 
 
 
Intangible assets, net
 
 
35,506
 
 
35,619
 
Other
 
 
4,852
 
 
4,551
 
 
 


 


 
Total other assets
 
 
40,358
 
 
40,170
 
 
 


 


 
Total assets
 
$
454,461
 
$
370,397
 
 
 


 


 
LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CURRENT LIABILITIES
 
 
 
 
 
 
 
Notes payable
 
$
19,000
 
$
—  
 
Current portion of long-term debt
 
 
10,000
 
 
—  
 
Other current liabilities
 
 
95,609
 
 
61,221
 
 
 


 


 
Total current liabilities
 
 
124,609
 
 
61,221
 
 
 


 


 
LONG-TERM DEBT, NET OF CURRENT PORTION
 
 
40,000
 
 
50,251
 
 
 


 


 
LONG-TERM OBLIGATIONS
 
 
3,602
 
 
3,631
 
 
 


 


 
DEFERRED INCOME TAXES
 
 
6,451
 
 
6,142
 
 
 


 


 
STOCKHOLDERS’ EQUITY
 
 
279,799
 
 
249,152
 
 
 


 


 
Total liabilities and stockholders’ equity
 
$
454,461
 
$
370,397
 
 
 


 


 

See notes to consolidated financial statements.
 
Page 4 of 24

 
CSS INDUSTRIES, INC. AND SUBSIDIARIES
 
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
 
 
 
Nine Months Ended December 31,
 
 
 

 
(In thousands)
 
2004
 
2003
 

 

 

 
Cash flows from operating activities:
 
 
 
 
 
 
 
Net income
 
$
35,177
 
$
37,574
 
 
 


 


 
Adjustments to reconcile net income to net cash used for operating activities:
 
 
 
 
 
 
 
Depreciation and amortization
 
 
10,451
 
 
10,252
 
Provision for doubtful accounts
 
 
260
 
 
917
 
Deferred tax provision
 
 
755
 
 
439
 
(Gain) loss on sale of assets
 
 
(120
)
 
255
 
Compensation expense related to stock options
 
 
165
 
 
—  
 
Changes in assets and liabilities:
 
 
 
 
 
 
 
Increase in accounts receivable
 
 
(174,515
)
 
(168,711
)
Decrease in inventory
 
 
12,807
 
 
28,230
 
Increase in other assets
 
 
(1,133
)
 
(662
)
Increase in other current liabilities
 
 
36,109
 
 
28,663
 
 
 


 


 
Total adjustments
 
 
(115,221
)
 
(100,617
)
 
 


 


 
Net cash (used for) operating activities
 
 
(80,044
)
 
(63,043
)
 
 


 


 
Cash flows from investing activities:
 
 
 
 
 
 
 
Purchase of property, plant and equipment
 
 
(6,905
)
 
(10,551
)
Proceed from sale of assets
 
 
223
 
 
3,702
 
 
 


 


 
Net cash (used for) investing activities
 
 
(6,682
)
 
(6,849
)
 
 


 


 
Cash flows from financing activities:
 
 
 
 
 
 
 
Payments on long-term obligations
 
 
(49
)
 
(172
)
Borrowings on notes payable
 
 
141,745
 
 
188,795
 
Repayments on notes payable
 
 
(122,745
)
 
(159,815
)
Dividends paid
 
 
(4,778
)
 
(2,668
)
Payment of fractional shares related to 3 for 2 stock split
 
 
—  
 
 
(2
)
Purchase of treasury stock
 
 
(6,815
)
 
—  
 
Proceeds from exercise of stock options
 
 
5,025
 
 
3,914
 
 
 


 


 
Net cash provided by financing activities
 
 
12,383
 
 
30,052
 
 
 


 


 
Effect of exchange rate changes on cash
 
 
(3
)
 
17
 
 
 


 


 
Net (decrease) in cash and cash equivalents
 
 
(74,346
)
 
(39,823
)
Cash and cash equivalents at beginning of period
 
 
93,191
 
 
51,981
 
 
 


 


 
Cash and cash equivalents at end of period
 
$
18,845
 
$
12,158
 
 
 


 


 
 
See notes to consolidated financial statements.
 
Page 5 of 24

 
CSS INDUSTRIES, INC. AND SUBSIDIARIES
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
December 31, 2004
(Unaudited)
 
(1)
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:
 
 
 
Basis of Presentation -
 
 
 
CSS Industries, Inc. (collectively with its subsidiaries, “CSS” or the “Company”) has prepared the consolidated financial statements included herein pursuant to the rules and regulations of the Securities and Exchange Commission.  The Company has condensed or omitted certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States pursuant to such rules and regulations.  In the opinion of management, the statements include all adjustments (which include normal recurring adjustments) required for a fair presentation of financial position, results of operations and cash flows for the interim periods presented.  These financial statements should be read in conjunction with the financial statements and notes thereto included in the latest Annual Report on Form 10-K.  The results of operations for the interim periods are not necessarily indicative of the results for the full year.
 
 
 
Principles of Consolidation -
 
 
 
The consolidated financial statements include the accounts of the Company and all of its subsidiaries. All significant intercompany transactions and accounts have been eliminated in consolidation.
 
 
 
Nature of Business -
 
 
 
CSS is a consumer products company primarily engaged in the design, manufacture and sale to mass market retailers of seasonal, social expression products, including gift wrap, gift bags, boxed greeting cards, gift tags, tissue paper, paper and vinyl decorations, classroom exchange Valentines, decorative ribbons and bows, Halloween masks, costumes, make-ups and novelties, Easter egg dyes and novelties and educational products.  The seasonal nature of CSS’ business results in low sales and operating losses in the first and fourth quarters and high shipment levels and operating profits in the second and third quarters of the Company’s fiscal year which ends March 31, thereby causing significant fluctuations in the quarterly results of operations of the Company.
 
 
 
Reclassification -
 
 
 
Certain prior period amounts have been reclassified to conform with the current period presentation.
 
 
 
Foreign Currency Translation and Transactions -
 
 
 
Translation adjustments are charged or credited to a separate component of stockholders’ equity. Gains and losses on foreign currency transactions are not material and are included in other expense (income), net in the consolidated statements of operations.
 
Page 6 of 24

 
 
Use of Estimates -
 
 
 
The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Judgments and assessments of uncertainties are required in applying the Company’s accounting policies in many areas.  Such estimates pertain to the valuation of inventory and accounts receivable, the assessment of the recoverability of goodwill and other intangible assets, income tax accounting and resolution of litigation and proceedings regarding the possible imposition of duties on tissue products. Actual results could differ from those estimates.
 
 
 
Inventories -
 
 
 
The Company records inventory at the date of taking title which generally occurs upon receipt or prior to receipt with regard to in-transit inventory of overseas product.  The Company adjusts unsaleable and slow-moving inventory to its net realizable value.  Substantially all of the Company’s inventories are stated at the lower of first-in, first-out (FIFO) cost or market.  The remaining portion of the inventory is valued at the lower of last-in, first-out (LIFO) cost or market.  Inventories consisted of the following (in thousands):
 
 
 
December 31,
2004
 
March 31,
2004
 
 
 

 

 
Raw material
 
$
23,687
 
$
17,878
 
Work-in-process
 
 
19,168
 
 
27,363
 
Finished goods
 
 
38,797
 
 
49,218
 
 
 


 


 
 
 
$
81,652
 
$
94,459
 
 
 


 


 
 
 
Revenue Recognition -
 
 
 
The Company recognizes revenue from product sales when the goods are shipped and title and risk of loss pass to the customer.  Provisions for allowances and rebates to customers, returns and other adjustments are provided in the same period that the related sales are recorded.
 
 
 
Stock-Based Compensation -
 
 
 
The Company applies Accounting Principles Board (“APB”) Opinion No. 25, “Accounting for Stock Issued to Employees,” and related interpretations in accounting for its stock option plans. Accordingly, compensation expense is generally not recognized for its stock-based compensation plans.  Had compensation expense for the Company’s stock option plans been determined based upon the fair value at the grant date for awards under these plans consistent with the methodology prescribed under Statement of Financial Accounting Standards (“SFAS”) No. 123, “Accounting for Stock-Based Compensation,” the Company’s net income and net income per share would have been decreased as follows:
 
Page 7 of 24

 
 
 
Three Months Ended
December 31,
 
Nine Months Ended
December 31,
 
 
 

 

 
(in thousands, except per share data)
 
2004
 
2003
 
2004
 
2003
 

 

 

 

 

 
Net income, as reported
 
$
23,971
 
$
27,397
 
$
35,177
 
$
37,574
 
Add: Total stock-based employee compensation expense included in the determination of net income, as reported
 
 
—  
 
 
—  
 
 
165
 
 
—  
 
Deduct: Total stock-based employee compensation expense determined under fair value based method for all awards, net of related tax effects
 
 
(746
)
 
(567
)
 
(2,040
)
 
(1,702
)
 
 


 


 


 


 
Pro forma net income
 
$
23,225
 
$
26,830
 
$
33,302
 
$
35,872
 
 
 


 


 


 


 
Net income per share:
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic - as reported
 
$
2.01
 
$
2.31
 
$
2.95
 
$
3.20
 
Basic - pro forma
 
$
1.94
 
$
2.27
 
$
2.79
 
$
3.06
 
Diluted - as reported
 
$
1.91
 
$
2.18
 
$
2.79
 
$
3.05
 
Diluted - pro forma
 
$
1.87
 
$
2.12
 
$
2.65
 
$
2.93
 
 
 
Net Income Per Common Share -
 
 
 
The following table sets forth the computation of basic net income per common share and diluted net income per common share for the three and nine months ended December 31, 2004 and 2003 (in thousands, except per share data):
 
 
 
Three Months Ended
December 31,
 
Nine Months Ended
December 31,
 
 
 

 

 
 
 
2004
 
2003
 
2004
 
2003
 
 
 

 

 

 

 
Numerator:
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income
 
$
23,971
 
$
27,397
 
$
35,177
 
$
37,574
 
 
 


 


 


 


 
Denominator:
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted average shares outstanding for basic income per common share
 
 
11,952
 
 
11,841
 
 
11,929
 
 
11,730
 
Effect of dilutive stock options
 
 
571
 
 
751
 
 
678
 
 
605
 
 
 


 


 


 


 
Adjusted weighted average shares outstanding for diluted income per common share
 
 
12,523
 
 
12,592
 
 
12,607
 
 
12,335
 
 
 


 


 


 


 
Basic net income per common share
 
$
2.01
 
$
2.31
 
$
2.95
 
$
3.20
 
Diluted net income per common share
 
$
1.91
 
$
2.18
 
$
2.79
 
$
3.05
 
 
 
Statements of Cash Flows -
 
 
 
For purposes of the consolidated statements of cash flows, the Company considers all holdings of highly liquid debt instruments with a purchased maturity of less than three months to be cash equivalents.
 
Page 8 of 24

 
 
 
(2)
DERIVATIVE FINANCIAL INSTRUMENTS:
 
 
 
The Company enters into foreign currency forward contracts in order to reduce the impact of certain foreign currency fluctuations.  Firmly committed transactions and the related receivables and payables may be hedged with foreign currency forward contracts.  Gains and losses arising from foreign currency forward contracts are recognized in income or expense as offsets of gains and losses resulting from the underlying hedged transactions.  As of December 31, 2004, the notional amount of open foreign currency forward contracts was $20,799,000 and the related loss was $1,453,000.
 
 
 
In 2001, the Company entered into interest rate swap agreements, with maturities through January 2004, to manage its exposure to interest rate movements by effectively converting a portion of its anticipated working capital debt from variable to fixed rates.  These agreements involved the Company receiving variable rate payments in exchange for fixed rate payments without the effect of leverage and without the exchange of the underlying face amount.  Variable rate payments were based on one month U.S. dollar LIBOR.  There were no interest rate swap contracts outstanding during the quarter or nine months ended December 31, 2004.  During the quarter and nine months ended December 31, 2003, interest rate differentials paid under these agreements were recognized as adjustments to interest expense and amounted to $235,000 and $435,000, respectively.
 
 
(3)
BUSINESS ACQUISITIONS AND DIVESTITURES:
 
 
 
Crystal Creative Products, Inc.
 
 
 
On October 18, 2002, a subsidiary of the Company acquired all of the capital stock of Crystal Creative Products, Inc. (“Crystal”) for $22,891,000, including transaction costs, and assumed and repaid $18,828,000 of outstanding debt (primarily seasonal working capital debt).  During fiscal 2004, the Company received cash of approximately $2,155,000 in satisfaction of a post closing adjustment to the purchase price.  Crystal, headquartered in Middletown, Ohio, was a leading designer, manufacturer and distributor of consumer convenience gift wrap products and competed in the seasonal end of the gift bag and tissue markets with the Company’s existing product lines.  At the time of acquisition, its product lines included gift tissue, gift bags, and related packaging products for the consumer market, as well as specialty tissues for in-store packaging of retailers and for industrial applications.  A portion of the purchase price is being held in escrow for certain indemnification obligations.  The acquisition was accounted for as a purchase and the excess of cost over the fair market value of the net tangible assets acquired of $9,877,000 was recorded as intangible assets in the accompanying consolidated balance sheets.  Of the $9,877,000 of acquired intangible assets, $4,290,000 was assigned to tradenames that are not subject to amortization, $5,287,000 was assigned to goodwill and $300,000 was assigned to a covenant not to compete which has a useful life of five years.
 
 
 
In July 2003, the Company finalized a restructuring plan related to the Crystal acquisition, under which the Company restructured its business to integrate the acquired entity with its current businesses.  In connection with this plan, the Company sold assets related to a non-core portion of the Crystal business for $3,525,000 in July 2003, and closed Crystal’s primary manufacturing facility in Maysville, Kentucky.  A separate administration building in Middletown, Ohio also closed in March 2004.  The Company recorded a restructuring reserve of $1,672,000 as part of purchase accounting, including severance related to approximately 150 employees.  Uncommitted restructuring accruals related to the closing of the Maysville facility were reversed against goodwill in the fourth quarter of fiscal 2004.  There were no payments made in the quarter ended December 31, 2004.  Payments of $367,000 (including $143,000 for severance costs) were made in the nine months ended December 31, 2004.  During the first quarter of fiscal 2005, the Company reopened the Maysville facility in response to the filing of an anti-dumping petition related to tissue products manufactured in China.
 
Page 9 of 24

 
 
Selected information relating to the Crystal restructuring reserve follows (in thousands):
 
 
 
Severance
 
Contractual
Obligations and
Facility Exit Costs
 
Total
 
 
 

 

 

 
Restructuring reserve as of March 31, 2004
 
$
143
 
$
224
 
$
367
 
Cash paid – fiscal 2005
 
 
(143
)
 
(224
)
 
(367
)
 
 


 


 


 
Restructuring reserve as of December 31, 2004
 
$
—  
 
$
—  
 
$
—  
 
 
 


 


 


 
 
 
C. M. Offray & Son, Inc.
 
 
 
On March 15, 2002, a subsidiary of the Company completed the acquisition of substantially all of the business and assets of the portion of C. M. Offray & Son, Inc. (“Offray”) which manufactures and sells decorative ribbon products, floral accessories and narrow fabrics for apparel, craft and packaging applications.  Berwick acquired substantially all of the  business and assets of Offray for $44,865,000 in cash, including transaction costs.  A portion of the purchase price is being held in escrow to cover indemnification obligations.  The acquisition was accounted for as a purchase and the cost approximated the fair market value of the net assets acquired.  Therefore, no goodwill was recorded in this transaction.
 
 
 
In conjunction with the acquisition of Offray, the Company’s management approved a restructuring plan. As part of this plan, the Company accrued $2,385,000 for severance and costs related to the closure of certain facilities.  As of December 31, 2004, the Company had closed Offray’s distribution facility in Quebec, Canada and its warehouse in Antietam, Maryland and has communicated termination of employment to approximately 125 employees.  Payments, mainly for severance, of  $17,000 and $233,000 were made in the quarter and in the nine months ended December 31, 2004.  These payments represent the final severance payments.  During the third quarter ended December 31, 2004, there was a reduction in the restructuring accrual of $77,000 related to severance costs that were less than originally estimated as certain employees under the plan did not receive the expected amount of severance.  There was a corresponding reduction in property, plant and equipment for this amount.
 
 
 
Selected information relating to the Offray restructuring reserve follows (in thousands):
 
 
 
Severance
 
Contractual
Obligations and
Facility Exit Costs
 
Total
 
 
 

 

 

 
Restructuring reserve as of March 31, 2004
 
$
310
 
$
92
 
$
402
 
Cash paid – fiscal 2005
 
 
(233
)
 
(92
)
 
(325
)
Non cash reduction – fiscal 2005
 
 
(77
)
 
—  
 
 
(77
)
 
 


 


 


 
Restructuring reserve as of December 31, 2004
 
$
—  
 
$
—  
 
$
—  
 
 
 


 


 


 
 
(4)
BUSINESS RESTRUCTURING:
 
 
 
On May 5, 2004, a subsidiary of the Company announced a restructuring of its business and established a restructuring reserve related to its administrative office located in Minneapolis, Minnesota.  This restructuring was established in order to gain efficiencies within the business unit.  As part of this restructuring plan, the Company accrued $377,000 for termination costs and costs related to the restructuring of the administrative office expected to be completed in December 2004.  As of December 31, 2004, the Company has communicated termination of employment to 33 employees.  Payments for termination costs of $243,000 and $298,000 were made in the quarter and nine months ended December 31, 2004, respectively.  Payments for contractual obligations of $37,000 and $97,000 were made in the quarter and nine months ended December 31, 2004, respectively.
 
Page 10 of 24

 
 
During the third quarter and in the nine months ended December 31, 2004, the Company increased the restructuring reserve related to the ratable recognition of retention bonuses for employees providing service until their termination date in the amount of $96,000 and $300,000, respectively.  Additionally, during the third quarter there was an increase in the restructuring reserve related to unutilized office space in the amount of $83,000.  These amounts are shown in selling, general and administrative expenses in the accompanying consolidated statement of operations.  As of December 31, 2004, the remaining liability of $365,000 was classified as a current liability in the accompanying condensed consolidated balance sheet and will be paid during the remainder of fiscal 2005. The Company anticipates incurring a total of $1,373,000, including $479,000 for termination costs and $894,000 for contractual obligations and facility exit costs, with such additional amounts being expensed over the remainder of fiscal 2005.
 
 
 
Selected information relating to the Minneapolis restructuring reserve follows (in thousands):
 
 
 
Termination
Costs
 
Contractual
Obligations and
Facility Exit Costs
 
Total
 
 
 


 


 


 
Initial accrual - May 2004
 
$
171
 
$
206
 
$
377
 
Cash paid – fiscal 2005
 
 
(298
)
 
(97
)
 
(395
)
Charges to expense – fiscal 2005
 
 
300
 
 
83
 
 
383
 
 
 


 


 


 
Restructuring reserve as of December 31, 2004
 
$
173
 
$
192
 
$
365
 
 
 


 


 


 
 
 
On November 1, 2004, a subsidiary of the Company announced the anticipated closure of its plant located in Anniston, Alabama.  As of December 31, 2004, the Company has communicated termination of employment to 89 employees.  Manufacturing operations will be moved to other locations of the Company and is expected to be completed by March 2005.  As part of this restructuring plan, the Company accrued $206,000 for severance costs.  There were no payments of severance made during the third quarter and as of December 31, 2004, this liability was classified as a current liability in the accompanying condensed consolidated balance sheet and will be paid during the remainder of fiscal 2005.  The Company anticipates incurring a total of $1,417,000, including $246,000 for termination costs and $1,171,000 for facility exit costs, with such amounts being expensed over the remainder of fiscal 2005.
 
 
(5)
GOODWILL AND INTANGIBLES:
 
 
 
Effective April 1, 2002, the Company adopted SFAS No. 142, “Goodwill and Other Intangible Assets.” Upon adoption of SFAS No. 142, amortization of goodwill and indefinite-lived intangible assets ceased.  The Company determined that its tradenames are indefinite-lived assets.
 
 
 
The Company performs the required annual impairment test of the carrying amount of goodwill and indefinite lived intangible assets in the fourth quarter of its fiscal year.
 
Page 11 of 24

 
 
Included in intangibles assets, net in the accompanying condensed consolidated balance sheets are the following acquired intangible assets (in thousands):
 
 
 
 
December 31,
2004
 
March 31,
2004
 
 
 

 

 
Goodwill
 
$
30,952
 
$
30,952
 
Tradenames
 
 
4,290
 
 
4,290
 
Non-compete and other
 
 
264
 
 
377
 
 
 


 


 
 
 
$
35,506
 
$
35,619
 
 
 


 


 
 
 
Amortization expense was $38,000 for the quarters ended December 31, 2004 and 2003 and was $113,000 for the nine months ended December 31, 2004 and 2003.  Based on the current composition of intangibles, amortization expense for each of the succeeding five years is projected to be as follows: three months ending March 31, 2005: $38,000; years ending March 31, 2006: $94,000; 2007: $94,000; 2008: $38,000; and 2009: $0.
 
 
(6)
DEBT ARRANGEMENTS:
 
 
 
On April 23, 2004, the Company’s $100,000,000 revolving credit facility was replaced with a $50,000,000 revolving credit facility with five banks.  This new facility expires on April 23, 2009.  The loan agreement contains provisions to increase or reduce the interest pricing spread based on the achievement of certain benchmarks related to the ratio of earnings to interest expense.  At the Company’s option, interest on the facility currently accrues at (1) the greater of the prime rate minus .5% or the Federal Funds Rate, or (2) LIBOR plus .75%.  The revolving credit facility provides for commitment fees of .225% per annum on the daily average of the unused commitment.  The loan agreement also contains covenants, the most restrictive of which pertain to net worth, the ratio of operating cash flow to fixed charges, the ratio of debt to capitalization and limitations on capital expenditures.
 
 
 
On April 23, 2004, the Company entered into an extension of its $100,000,000 accounts receivable securitization facility during which time it renewed the facility for a five-year period, expiring on July 25, 2009, although it may terminate prior to such date in the event of the termination of the commitments of the facility’s back-up purchasers.  The facility limit now has a seasonally-adjusted funding limit of $100,000,000 during peak seasonal periods and $25,000,000 during off-peak seasonal periods.  Interest on amounts financed under this facility are based on a variable commercial paper rate plus .375% and provides for commitment fees of .225% per annum on the daily average of the unused commitment.
 
 
(7)
COMMITMENTS AND CONTINGENCIES:
 
 
 
As described in Item 3 of the Company’s annual report on Form 10-K for the fiscal year ended March 31, 2004, a group of six domestic producers of tissue paper products and a labor union filed an anti-dumping duty petition with the U.S. Commerce Department (“Commerce Department”) and the U.S. International Trade Commission (“ITC”) on February 17, 2004.  The petitioners are seeking the imposition of duties of 163.36% on certain tissue paper products imported from China.  If the petitioners are successful, duties will be imposed on certain tissue paper products that the Company imports from China.
 
 
 
In September 2004, the Commerce Department issued its preliminary determination in the anti-dumping duty investigation on certain tissue paper products imported from China.  As a result of this determination, the Company and other importers are required to post bond or a cash deposit upon importation of these products at rates reflecting the Commerce Department’s estimate of the duties that may be imposed on these products.  In November 2004 and January 2005, the Commerce Department
 
Page 12 of 24

 
 
denied requests to reduce these deposit rates pending the issuance of its final determination.  The actual amount of the duties, if imposed, may be higher or lower than the deposit rates, depending on the final determinations of the Commerce Department and the ITC, which are expected to be issued in February 2005 and March 2005, respectively, and any reviews that may be undertaken by the Commerce Department thereafter.  The Company’s exposure is estimated to be in the range of approximately $.03 to $.16 per diluted share.  The Company is vigorously contesting the imposition of these duties, however given the preliminary determinations of the Commerce Department and the ITC, the Company has fully established a pre-tax reserve for its estimated maximum exposure of $3,100,000, or $.16 per share, in the quarter ended December 31, 2004.
 
 
 
In order to mitigate the effect of any duties that may be imposed as a result of these proceedings, the Company resumed tissue-converting operations at the Company’s previously-closed facility in Maysville, Kentucky, and developed alternative sourcing arrangements.
 
 
(8)
PENSION AND OTHER POSTRETIREMENT OBLIGATIONS:
 
 
 
The Company’s Cleo subsidiary administers a defined benefit pension plan covering substantially all salaried employees of Crystal.  The plan, acquired as part of the Crystal acquisition on October 18, 2002, was frozen on November 2, 2002 and terminated September 30, 2003.  Future benefits to Crystal division employees will be provided by participation in an existing defined contribution profit sharing and 401(k) plan.  The Company’s Cleo subsidiary also administers a post-retirement medical plan covering certain employees of the former Crystal division.  The plan was frozen to new participants prior to Crystal’s acquisition by the Company.
 
 
 
The components of net pension and other post-retirement benefit cost are as follows (in thousands):
 
 
 
Nine Months Ended December 31,
 
 
 

 
 
 
2004
 
2003
 
2004
 
2003
 
 
 

 

 

 

 
 
 
Pension Benefits
 
Other Benefits
 
 
 

 

 
Interest cost
 
$
48
 
$
83
 
$
44
 
$
64
 
Expected return on plan assets
 
 
(111
)
 
(251
)
 
—  
 
 
—  
 
 
 


 


 


 


 
Benefit cost (credit)
 
$
(63
)
$
(168
)
$
44
 
$
64
 
 
 


 


 


 


 
 
 
 
Three Months Ended December 31,
 
 
 

 
 
 
2004
 
2003
 
2004
 
2003
 
 
 

 

 

 

 
 
 
Pension Benefits
 
Other Benefits
 
 
 

 

 
Interest cost
 
$
16
 
$
28
 
$
15
 
$
21
 
Expected return on plan assets
 
 
(37
)
 
(84
)
 
—  
 
 
—  
 
 
 


 


 


 


 
Benefit cost (credit)
 
$
(21
)
$
(56
)
$
15
 
$
21
 
 
 


 


 


 


 
 
 
In May 2004, the Financial Accounting Standards Board (“FASB”) issued FASB Staff Position 106-2 (FSP 106-2), “Accounting and Disclosure Requirements Related to the Medicare Prescription Drug, Improvement and Modernization Act of 2003” (the “Act”).  FSP 106-2 provides guidance on the accounting for the effects of the Act for employers that sponsor postretirement health care plans that provide prescription drug benefits.  FSP 106-2 became effective on July 1, 2004 for the Company and, based on management’s review of the benefits provided under its post-retirement plans, the enactment of the Act did not constitute a significant event and the impact of the Act on its post-retirement plan will be recognized on the next measurement date of the plan, which is March 31, 2005.  Management does not anticipate that there will be a material impact on its financial condition or results of operations as a result of adopting the provisions of FSP 106-2.
 
Page 13 of 24

 
(9)
ACCOUNTING PRONOUNCEMENTS:
 
 
 
In January 2003, the FASB issued FIN 46, “Consolidation of Variable Interest Entities (VIE), an Interpretation of ARB No. 51,” which requires all VIEs to be consolidated by the primary beneficiary.  The primary beneficiary is the entity that holds the majority of the beneficial interests in the VIE.  In December 2003, the FASB revised FIN 46 (“FIN 46R”), delaying the effective dates for certain entities created before February 1, 2003, and making other amendments to clarify application of the guidance.  FIN 46R requires certain disclosures of an entity’s relationship with variable interest entities.  FIN 46R was effective for companies with interests in variable interest entities or potential variable interest entities (commonly referred to as special-purpose entities, or SPEs) for periods ending after December 15, 2003.  FIN 46R was effective for companies with all other types of entities (i.e. non-SPEs) for periods ending after March 15, 2004.  The adoption of FIN 46R had no impact on the Company’s financial position or results of operations.
 
 
 
In April 2003, the FASB issued SFAS No. 149, “Amendment of Statement 133 on Derivative Instruments and Hedging Activities.”  SFAS No. 149 clarifies under what circumstances a contract with an initial net investment meets the characteristics of a derivative and when a derivative contains a financing component.  This statement is effective for contracts entered into or modified after June 30, 2003.  The adoption of this statement had no impact on the Company’s financial position or results of operations.
 
 
 
In May 2003, the FASB issued SFAS No. 150, “Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity,” which requires that certain financial instruments that were previously presented as equity or as temporary equity to be presented as liabilities.  Such instruments include mandatory redeemable preferred and common stock, and certain options and warrants.  SFAS No. 150 was effective for financial instruments entered into or modified after May 31, 2003 and was applied to the Company’s existing financial instruments effective July 1, 2003, the beginning of the first fiscal period after June 15, 2003.  The Company adopted SFAS No. 150 for new or modified financial instruments on June 1, 2003.  The adoption of this statement had no impact on the Company’s financial position or results of operations.
 
 
 
In December 2003, the FASB revised SFAS No. 132, “Employers’ Disclosures about Pensions and other Postretirement Benefits,” establishing additional annual disclosures about plan assets, investment strategy, measurement date, plan obligations and cash flows.  In addition, the revised standard established interim disclosure requirements related to the net periodic benefit cost recognized and contributions paid or expected to be paid during the current fiscal year.  The new annual disclosures are effective for financial statements with fiscal years ending after December 15, 2003 and the interim-period disclosures are effective for interim periods beginning after December 15, 2003.  The Company adopted the disclosures for its fiscal year ending March 31, 2004 and in its interim fiscal 2005 periods.  The adoption of this statement had no impact on the Company’s financial position or results of operations.
 
 
 
In November 2004, the FASB issued SFAS No. 151, “Inventory Costs, an amendment of ARB No. 43, Chapter 4,” which amends the guidance in ARB No. 43, Chapter 4, “Inventory Pricing” to clarify the accounting for abnormal amounts of idle facility expense, freight, handling costs and spoilage.  This statement now requires that these costs be expensed as current period charges. In addition, this statement requires that the allocation of fixed production overhead to the costs of conversion be based on the normal capacity of the production facilities.  The provisions of this statement are effective for inventory costs incurred during fiscal years beginning after June 15, 2005.  The Company has not yet assessed the impact of this statement on the Company’s financial position or results of operations.
 
Page 14 of 24

 
 
In December 2004, the FASB issued SFAS No. 153, “Exchanges of Nonmonetary Assets, an amendment of APB Opinion No. 29,” which eliminates the APB Opinion No. 29 exception for nonmonetary exchanges of similar productive assets and replaces it with a general exception for exchanges of nonmonetary assets that do not have commercial substance.  Commercial substance exists if the future cash flows of the entity are expected to change significantly as a result of the exchange.  The provisions of this statement are effective for nonmonetary asset exchanges occurring in fiscal periods beginning after June 15, 2005.
 
 
 
In December 2004, the FASB issued SFAS No. 123(R), “Share-Based Payment,” a revision to SFAS 123, “Accounting for Stock-Based Compensation.”  This statement supersedes APB Opinion No. 25, “Accounting for Stock Issued to Employees.”  SFAS No. 123(R) establishes standards for the accounting for transactions in which an entity exchanges its equity instruments for goods or services. This statement requires that the cost of share based payment transactions be recorded as an expense at their fair value determined by applying a fair value measurement method.  The provisions of this statement are effective as of the first interim reporting period beginning after June 15, 2005 (period ending September 30, 2005).  Reference is made to footnote No. 1, Summary of Significant Accounting Policies, for the SFAS No. 123 impact on net income and net income per share.
 
Page 15 of 24

 
CSS INDUSTRIES, INC. AND SUBSIDIARIES
 
ITEM 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL
 
CONDITION AND RESULTS OF OPERATIONS
 
STRATEGIC OVERVIEW
 
The Company’s business is roughly 75% seasonal (Christmas, Valentines, Easter and Halloween products), with the remainder being everyday product sales.  Seasonal products are sold primarily to mass market retailers and the Company typically has relatively high market shares in many of these categories.  Most of these markets have shown little or no growth in recent years and there continues to be significant cost pressure in this area as our competitors source certain products overseas and our customers increase direct sourcing from overseas factories.  Increasing customer concentration and bargaining power also contribute to price pressure.
 
The Company is responding to these pressures in a number of ways.  First, we are increasing our investment in product and packaging design and product knowledge to assure we can continue to provide unique added value to our customers.  Secondly, we have opened a new office and showroom in the Far East to better meet our customers’ buying needs and to be able to provide alternatively sourced products at competitive prices.  Lastly, we increased our focus on efficiency and productivity in our North American production and distribution facilities to assure our competitiveness domestically.
 
Our everyday product lines, principally craft, floral and packaging products, have high inherent growth potential due to higher market growth rates, particularly in craft, and to our relatively low current market shares.  We have established project teams to pursue top line sales growth in these and other areas.
 
The Company has experienced cost increases in certain key materials.  These increases will impact fiscal 2006 and will require that management either obtain price increases from its customers or find other means of reducing material costs in the products its sells.
 
Historically, significant growth at CSS has come through carefully chosen and executed acquisitions.  Management anticipates that it will continue this pursuit in the future, as well.
 
LITIGATION
 
As described in Item 3 of the Company’s annual report on Form 10-K for the fiscal year ended March 31, 2004, a group of six domestic producers of tissue paper products and a labor union filed an anti-dumping duty petition with the U.S. Commerce Department (“Commerce Department”) and the U.S. International Trade Commission (“ITC”) on February 17, 2004.  The petitioners are seeking the imposition of duties of 163.36% on certain tissue paper products imported from China.  If the petitioners are successful, duties will be imposed on certain tissue paper products that the Company imports from China.
 
In September 2004, the Commerce Department issued its preliminary determination in the anti-dumping duty investigation on certain tissue paper products imported from China.  As a result of this determination, the Company and other importers are required to post bond or a cash deposit upon importation of these products at rates reflecting the Commerce Department’s estimate of the duties that may be imposed on these products.  In November 2004 and January 2005, the Commerce Department denied requests to reduce these deposit rates pending the issuance of its final determination.  The actual amount of the duties, if imposed, may be higher or lower than the deposit rates, depending on the final determinations of the Commerce Department and the ITC, which are expected to be issued in February 2005 and March 2005, respectively, and any reviews that may be undertaken by the Commerce Department thereafter.  The Company’s exposure is estimated to be in the range of approximately $.03 to $.16 per diluted share.  The Company is vigorously contesting the imposition of these duties, however given the preliminary
 
Page 16 of 24

 
determinations of the Commerce Department and the ITC, the Company has fully established a pre-tax reserve for its estimated maximum exposure of $3,100,000, or $.16 per share, in the quarter ended December 31, 2004.
 
In order to mitigate the effect of any duties that may be imposed as a result of these proceedings, the Company resumed tissue-converting operations at the Company’s previously-closed facility in Maysville, Kentucky, and developed alternative sourcing arrangements.
 
CRITICAL ACCOUNTING POLICIES
 
The consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States.  The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.
 
The significant accounting policies of the Company are described in the notes to the consolidated financial statements included in the Annual Report on Form 10-K.  Judgments and estimates of uncertainties are required in applying the Company’s accounting policies in many areas.  Following are some of the areas requiring significant judgments and estimates: useful lives of plant and equipment; cash flow and valuation assumptions in performing asset impairment tests of long-lived assets and goodwill; valuation reserves for inventory and accounts receivable; income tax accounting and resolution of litigation and proceedings regarding the possible imposition of duties on tissue products.
 
RESULTS OF OPERATIONS
 
Seasonality
 
The seasonal nature of CSS’ business results in low sales and operating losses in the first and fourth quarters and high shipment levels and operating profits in the second and third quarters of the Company’s fiscal year which ends March 31, thereby causing significant fluctuations in the quarterly results of operations of the Company.
 
Nine Months Ended December 31, 2004 Compared to Nine Months Ended December 31, 2003
 
Sales for the nine months ended December 31, 2004 decreased 1% to $478,435,000 from $484,846,000 in 2003 primarily due to lower sales of ribbons and bows, the absence of sales related to a product line which was sold in July of 2003 and the later timing of Valentine shipments to a major customer which pushed sales into the fourth quarter.  This sales decline was partially offset by higher sales of Christmas and everyday boxed greeting cards.
 
Cost of sales, as a percentage of sales, was 74% in 2004 and 72% in 2003.  The increase in cost of sales is substantially due to lower gross margins caused by our establishment of a reserve of $3,100,000 for duties that may be imposed on imported tissue products, higher freight costs and higher material costs, particularly paper based and polypropylene based raw materials.
 
Selling, general and administrative (“SG&A”) expenses, as a percentage of sales, were 14% in 2004 and 15% in 2003.  The decrease in SG&A expenses of $4,052,000, or 6%, over the prior year nine months is primarily due to lower compensation costs and integration savings related to recent acquisitions, partially offset by costs incurred related to the Minneapolis restructuring plan and incremental costs related to compliance with Section 404 of the Sarbanes-Oxley Act (“SOX 404”) requirements.
 
Interest expense, net was $2,032,000 in 2004 and $2,874,000 in 2003.  The decrease in interest expense was primarily due to lower borrowing levels as a result of the cash generated from operations and
 
Page 17 of 24

 
improved management of working capital, partially offset by higher interest rates.
 
Income taxes, as a percentage of income before taxes, were 36% in 2004 and 2003.
 
Net income for the nine months ended December 31, 2004 was $35,177,000, or $2.79 per diluted share compared to $37,574,000, or $3.05 per diluted share in 2003.  The decrease in net income is primarily attributable to lower sales and margins, partially offset by reduced compensation costs, integration savings and lower interest expense.
 
Three Months Ended December 31, 2004 Compared to Three Months Ended December 31, 2003
 
Sales for the quarter ended December 31, 2004 of $247,169,000 were flat compared to prior year sales of $247,394,000 primarily as a result of the later timing of Valentine shipments to a major customer which pushed sales into the fourth quarter and lower sales of gift wrap, tissue products and ribbons and bows.  This sales decline was largely offset by higher sales of Christmas and everyday boxed greeting cards.
 
Cost of sales, as a percentage of sales, was 75% in 2004 and 71% in 2003.  The increase in cost of sales is primarily a result of lower gross margins caused by our establishment of a reserve of $3,100,000 for duties that may be imposed on imported tissue products, higher freight costs and higher material costs, particularly paper based and polypropylene based raw materials.
 
SG&A expenses, as a percentage of sales, were 10% in 2004 and 11% in 2003.  The decrease in SG&A expenses of $2,827,000, or 10%, over the prior year quarter is attributable to the result of lower compensation costs and integration savings related to recent acquisitions, partially offset by costs incurred related to the Minneapolis restructuring plan and incremental costs related to compliance with SOX 404 requirements.
 
Interest expense, net was $906,000 in 2004 and $1,185,000 in 2003.  The decrease in interest expense was primarily due to lower borrowing levels, partially offset by higher interest rates.
 
Income taxes, as a percentage of loss before taxes, were 36% in 2004 and 2003.
 
Net income for the three months ended December 31, 2004 was $23,971,000, or $2.01 per diluted share compared to $27,397,000, or $2.18 per diluted share in 2003.  The decrease in net income is primarily attributable to the impact of lower sales and margins, partially offset by lower compensation costs and acquisition integration savings.
 
LIQUIDITY AND CAPITAL RESOURCES
 
At December 31, 2004, the Company had working capital of $211,813,000 and stockholders’ equity of $279,799,000.  The increase in accounts receivable from March 31, 2004 reflected seasonal billings of current year Christmas accounts receivables, net of current year collections.   The decrease in inventories reflected normal seasonal shipments during the fiscal 2005 shipping season.  The increase in other current liabilities was due to increased accruals for income taxes, sales commissions, royalties and employee benefits.  The increase in stockholders’ equity was primarily attributable to the year-to-date net income and capital contributed upon exercise of employee stock options, partially offset by treasury share repurchases and payments of cash dividends.
 
The Company relies primarily on cash generated from operations and seasonal borrowings to meet its liquidity requirements.  Historically, most revenues are seasonal with approximately 80% of sales generated in the second and third quarters.  Payment for Christmas related products is usually not received
 
Page 18 of 24

 
until after the holiday selling season in accordance with general industry practice.  As a result, short-term borrowing needs increase through December and peak prior to Christmas. Seasonal borrowings are made under a $50,000,000 revolving credit facility with five banks and a receivable purchase agreement in an amount up to $100,000,000 with an issuer of receivables-backed commercial paper.  In addition, the Company has outstanding $50,000,000 of 4.48% senior notes due ratably in annual installments over five years beginning in December 2005.  These financing facilities are available to fund the Company’s seasonal borrowing needs and to provide the Company with sources of capital for general corporate purposes, including acquisitions as permitted under the revolving credit facility.  At December 31, 2004, there was $50,000,000 of long-term borrowings outstanding related to the senior notes and $19,000,000 outstanding under the Company’s short-term credit facilities.  Based on its current operating plan, the Company believes its sources of available capital are adequate to meet its ongoing cash needs for at least the next 12 months.
 
As of December 31, 2004, the Company’s contractual obligations and commitments are as follows (in thousands):
 
 
 
Less than 1
Year
 
1-3
Years
 
4-5
Years
 
After 5
Years
 
Total
 
 
 

 

 

 

 

 
Short-term debt
 
$
19,000
 
$
—  
 
$
—  
 
$
—  
 
$
19,000
 
Capital lease obligations
 
 
307
 
 
—  
 
 
—  
 
 
—  
 
 
307
 
Operating leases
 
 
7,093
 
 
9,715
 
 
7,098
 
 
2,974
 
 
26,880
 
Long-term debt
 
 
10,000
 
 
20,000
 
 
20,000
 
 
0
 
 
50,000
 
Other long-term obligations
 
 
230
 
 
1,149
 
 
86
 
 
2,367
 
 
3,832
 
 
 


 


 


 


 


 
 
 
$
36,630
 
$
30,864
 
$
27,184
 
$
5,341
 
$
100,019
 
 
 


 


 


 


 


 
 
Other long-term obligations consist primarily of medical postretirement liabilities and deferred compensation arrangements.  Future timing of payments for other long-term obligations represent management’s best estimate.

As of December 31, 2004, the Company’s other commitments are as follows (in thousands):
 
 
 
Less than 1
Year
 
1-3
Years
 
4-5
Years
 
After 5
Years
 
Total
 
 
 


 


 


 


 


 
Letters of credit
 
$
11,312
 
$
—  
 
$
—  
 
$
—  
 
$
11,312
 
 
The Company has letters of credit that guarantee funding of workers compensation claims as well as obligations to certain vendors.  The Company has no financial guarantees or other arrangements with any third parties or related parties other than its subsidiaries.
 
In the ordinary course of business, the Company enters into arrangements with vendors to purchase merchandise in advance of expected delivery.  These purchase orders do not contain any significant termination payments or other penalties if cancelled.
 
Page 19 of 24

 
ACCOUNTING PRONOUNCEMENTS
 
In January 2003, the Financial Accounting Standard Board (“FASB”) issued Interpretation No. 46, “Consolidation of Variable Interest Entities.”  In April 2003, the FASB issued Statement of Financial Accounting Standard (“SFAS”) No. 149, “Amendment of Statement 133 on Derivative Instruments and Hedging Activities.”  In May 2003, the FASB issued SFAS No. 150, “Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity.”  In December 2003, the FASB revised SFAS No. 132, “Employers’ Disclosures about Pensions and Other Postretirement Benefits.”  In May 2004, the FASB issued FASB Staff Position (“FSP”) No. 106-2, “Accounting and Disclosure Requirements Related to the Medicare Prescription Drug, Improvement and Modernization Act of 2003.” In November 2004, the FASB issued SFAS No. 151, “Inventory Costs, an amendment of ARB No. 43, Chapter 4.”  In December 2004, the FASB issued SFAS No. 153, “Exchanges of Nonmonetary Assets, an amendment of APB Opinion No. 29” and SFAS No. 123(R), “Share-Based Payment.”  See the notes to the consolidated financial statements for information concerning the Company’s implementation and impact of these standards.
 
ITEM 3.  QUANTITIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
 
The Company is exposed to the impact of interest rate changes and manages this exposure through the use of variable-rate and fixed-rate debt.  The Company does not enter into contracts for trading purposes and does not use leveraged instruments.  The market risks associated with debt obligations and other significant instruments as of December 31, 2004 has not materially changed from March 31, 2004 (See Item 7A of the Annual Report on Form 10-K).
 
ITEM 4.  CONTROLS AND PROCEDURES
 
(a)
Evaluation of Disclosure Controls and Procedures.  As of the end of the period covered by this report, with the participation of the Company’s management, the Company’s President and Chief Executive Officer and Vice President – Finance and Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures in accordance with Rule 13a-15 of the Securities Exchange Act of 1934 (the “Exchange Act”).  Based upon that evaluation, the President and Chief Executive Officer and Vice President – Finance and Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective in providing reasonable assurance that information required to be disclosed by the Company in reports that it files under the Exchange Act is recorded, processed, summarized and reported within the time period specified in the Commission’s rules and procedures.
 
 
(b)
Changes in Internal Controls.  The evaluation referred to above did not identify any changes in the Company’s internal control over financial reporting that occurred during the quarter ended December 31, 2004 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
 
Page 20 of 24

 
CSS INDUSTRIES, INC. AND SUBSIDIARIES
 
PART II - OTHER INFORMATION
 
Item 1.  Legal Proceedings
 
As described in Item 3 of the Company’s annual report on Form 10-K for the fiscal year ended March 31, 2004, a group of six domestic producers of tissue paper products and a labor union filed an anti-dumping duty petition with the U.S. Commerce Department (“Commerce Department”) and the U.S. International Trade Commission (“ITC”) on February 17, 2004.  The petitioners are seeking the imposition of duties of 163.36% on certain tissue paper products imported from China.  If the petitioners are successful, duties will be imposed on certain tissue paper products that the Company imports from China.
 
In September 2004, the Commerce Department issued its preliminary determination in the anti-dumping duty investigation on certain tissue paper products imported from China.  As a result of this determination, the Company and other importers are required to post bond or a cash deposit upon importation of these products at rates reflecting the Commerce Department’s estimate of the duties that may be imposed on these products.  In November 2004 and January 2005, the Commerce Department denied requests to reduce these deposit rates pending the issuance of its final determination.  The actual amount of the duties, if imposed, may be higher or lower than the deposit rates, depending on the final determinations of the Commerce Department and the ITC, which are expected to be issued in February 2005 and March 2005, respectively, and any reviews that may be undertaken by the Commerce Department thereafter.  The Company’s exposure is estimated to be in the range of approximately $.03 to $.16 per diluted share.  The Company is vigorously contesting the imposition of these duties, however given the preliminary determinations of the Commerce Department and the ITC, the Company has fully established a pre-tax reserve for its estimated maximum exposure of $3,100,000, or $.16 per share, in the quarter ended December 31, 2004.
 
In order to mitigate the effect of any duties that may be imposed as a result of these proceedings, the Company resumed tissue-converting operations at the Company’s previously-closed facility in Maysville, Kentucky, and developed alternative sourcing arrangements. 
 
Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds
 
Share Repurchase Program
 
As of December 31, 2004, the Company repurchased 6,240,276 shares of CSS common stock, consisting of the shares repurchased pursuant to the repurchase program described below and an additional 1,650,000 shares (on a split-adjusted basis) purchased on June 24, 2002 from the Company’s Chairman, members of his family and a trust for members of his family.  A total of 7,700 shares were repurchased at an average price of $31.64, in the third quarter of fiscal 2005.  As of December 31, 2004, there remained an outstanding authorization to repurchase 509,724 shares of outstanding CSS common stock as represented in the table below.
 
Page 21 of 24

 
 
 
Total Number
of Shares
Purchased
 
Average Price
Paid per Share
 
Total Number of
Shares Purchased as
Part of Publicly
Announced Program (1)(2)
 
Maximum
Number of Shares
that May Yet Be
Purchased Under
the Program
 
 
 

 

 

 

 
October 1 through October 31, 2004
 
 
7,700
 
$
31.64
 
 
7,700
 
 
509,724
 
November 1 through November 30, 2004
 
 
—  
 
 
—  
 
 
—  
 
 
509,724
 
December 1 through December 31, 2004
 
 
—  
 
 
—  
 
 
—  
 
 
509,724
 
 
 


 


 


 


 
Total Second Quarter
 
 
7,700
 
$
31.64
 
 
7,700
 
 
509,724
 
 
 


 


 


 


 
 
(1)
The Company announced that its Board of Directors had authorized on February 18, 1998 the repurchase of up to 1,000,000 shares of the Company’s common stock (the “Repurchase Program”).  Thereafter, the Company announced that its Board of Directors had increased the number of shares authorized to be repurchased by the Company pursuant to the Repurchase Program as follows: November 9, 1998 (500,000 additional shares); May 4, 1999 (500,000 additional shares); September 28, 1999 (500,000 additional shares); September 26, 2000 (500,000 additional shares); and February 27, 2003 (400,000 additional shares).  As a result of the Company’s three-for-two stock split distributed on July 10, 2003, the number of shares authorized for repurchase pursuant to the Repurchase Program was automatically increased to 5,100,000 shares.  The aggregate number of shares repurchased by the Company pursuant to the Repurchase Program as of December 31, 2004 was 4,590,276 on a split-adjusted basis.  An expiration date has not been established for the Repurchase Program.
 
 
(2)
All open market share repurchases were effected in accordance with the safe harbor provisions of Rule 10b-18 of the Securities Exchange Act.
 
 
Item 6.
Exhibits
 
 
 
Exhibit 10.1 Employment Agreement dated as of December 1, 2004 between CSS Industries, Inc. and Richard L. Morris.
 
 
 
Exhibit 31.1 Certification of the Chief Executive Officer of CSS Industries, Inc. Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 302 of the Sarbanes – Oxley Act of 2002.
 
 
 
Exhibit 31.2 Certification of the Chief Financial Officer of CSS Industries, Inc. Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 302 of the Sarbanes – Oxley Act of 2002.
 
 
 
Exhibit 32.1 Certification of the Chief Executive Officer of CSS Industries, Inc. Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes – Oxley Act of 2002.
 
 
 
Exhibit 32.2 Certification of the Chief Financial Officer of CSS Industries, Inc. Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes – Oxley Act of 2002.
 
Page 22 of 24

 
SIGNATURES
 
          Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
CSS INDUSTRIES, INC.
 

 
(Registrant)
 
 
 
Date: January 26, 2005
By:
/s/ DAVID J. M. ERSKINE
 
 

 
 
David J. M. Erskine
President and Chief
Executive Officer
 
 
 
Date: January 26, 2005
By:
/s/ CLIFFORD E. PIETRAFITTA
 
 

 
 
Clifford E. Pietrafitta
Vice President – Finance,
Chief Financial Officer and
Principal Accounting Officer
 
Page 23 of 24

 
EXHIBIT INDEX
 
Exhibit No.
 
 

 
 
10.1
 
Employment Agreement dated as of December 1, 2004 between CSS Industries, Inc. and Richard L. Morris.
 
 
 
31.1
 
Certification of the Chief Executive Officer of CSS Industries, Inc. Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 302 of the Sarbanes – Oxley Act of 2002.
 
 
 
31.2
 
Certification of the Chief Financial Officer of CSS Industries, Inc. Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 302 of the Sarbanes – Oxley Act of 2002.
 
 
 
32.1
 
Certification of the Chief Executive Officer of CSS Industries, Inc. Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes – Oxley Act of 2002.
 
 
 
32.2
 
Certification of the Chief Financial Officer of CSS Industries, Inc. Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes – Oxley Act of 2002.
 
Page 24 of 24